Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 649 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Lantern Pharma Inc.
Market Cap
$12.27M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$12.48M
Operating Margin
-1315.51%
TTM Avg
-120503.86%
3Y Avg
-60605.86%
5Y Avg
-40403.91%
Market Cap
$12.63M
Operating Margin
-5.39%
TTM Avg
-4.88%
3Y Avg
-13.74%
5Y Avg
-13.69%
Market Cap
$11.78M
Operating Margin
-5652.38%
TTM Avg
-2826.19%
3Y Avg
-9617.03%
5Y Avg
-6411.35%
Market Cap
$13.06M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$13.17M
Operating Margin
-1062.29%
TTM Avg
-1250.55%
3Y Avg
-3518.84%
5Y Avg
-2345.89%
Market Cap
$11.30M
Operating Margin
0.00%
TTM Avg
14.10%
3Y Avg
7.05%
5Y Avg
-9488.72%
Market Cap
$11.27M
Operating Margin
-21.94%
TTM Avg
-34.04%
3Y Avg
-49.86%
5Y Avg
-59.16%
Market Cap
$13.29M
Operating Margin
-33.37%
TTM Avg
-42.32%
3Y Avg
-69.57%
5Y Avg
-60.22%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lantern Pharma Inc. (LTRN) | $12.27M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dare Bioscience, Inc. (DARE)vs › | $12.48M | -1315.51% | -120503.86% | -60605.86% | -40403.91% |
| IRIDEX Corporation (IRIX)vs › | $12.63M | -5.39% | -4.88% | -13.74% | -13.69% |
| Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs › | $11.78M | -5652.38% | -2826.19% | -9617.03% | -6411.35% |
| Cellectar Biosciences, Inc. (CLRB)vs › | $13.06M | 0.00% | 0.00% | 0.00% | 0.00% |
| Optimi Health Corp. (OPTH)vs › | $13.17M | -1062.29% | -1250.55% | -3518.84% | -2345.89% |
| Kiora Pharmaceuticals, Inc. (KPRX)vs › | $11.30M | 0.00% | 14.10% | 7.05% | -9488.72% |
| Biofrontera Inc. (BFRI)vs › | $11.27M | -21.94% | -34.04% | -49.86% | -59.16% |
| Cytosorbents Corporation (CTSO)vs › | $13.29M | -33.37% | -42.32% | -69.57% | -60.22% |
| CytoMed Therapeutics Limited (GDTC)vs › | $11.24M | N/A | -2960.13% | -1713.73% | -1142.49% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
